Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GSKY
2701
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.2M | ﹤0.01% |
105,812
-233,721
| -69% | -$2.74M |
|
2702
YPF
YPF
$206B
| $1.2M | ﹤0.01% |
312,660
-82,591
| -21% | -$346K |
|
|
ATRI
2703
DELISTED
Atrion Corp
ATRI
| $1.19M | ﹤0.01% |
1,692
+1,070
| +172% | +$770K |
|
2704
CALL
Sanofi
SNY
$103B
| $1.19M | ﹤0.01% |
+23,800
| New | +$1.18M |
|
2705
The Joint Corp
JYNT
$118M
| $1.19M | ﹤0.01% |
18,108
+3,126
| +21% | +$252K |
|
|
HTBK
2706
DELISTED
Heritage Commerce
HTBK
| $1.19M | ﹤0.01% |
99,543
+49,081
| +97% | +$573K |
|
2707
Replimune Group
REPL
$941M
| $1.19M | ﹤0.01% |
43,750
-3,205
| -7% | -$95.9K |
|
2708
Dolby
DLB
$5.51B
| $1.19M | ﹤0.01% |
12,447
-16,719
| -57% | -$1.5M |
|
2709
PUT
Helmerich & Payne
HP
$3.45B
| $1.19M | ﹤0.01% |
50,000
| – | – |
|
2710
Tilray
TLRY
$618M
| $1.19M | ﹤0.01% |
16,859
-2,427
| -13% | -$244K |
|
2711
Saic
SAIC
$4.95B
| $1.18M | ﹤0.01% |
14,159
-18,468
| -57% | -$1.6M |
|
2712
CALL
American Express
AXP
$227B
| $1.18M | ﹤0.01% |
7,200
| – | – |
|
2713
John B. Sanfilippo & Son
JBSS
$967M
| $1.17M | ﹤0.01% |
12,973
+3,927
| +43% | +$336K |
|
2714
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $1.17M | ﹤0.01% |
69,282
+51,717
| +294% | +$897K |
|
2715
German American Bancorp
GABC
$1.91B
| $1.17M | ﹤0.01% |
29,997
+9,292
| +45% | +$372K |
|
2716
Karyopharm Therapeutics
KPTI
$43.5M
| $1.17M | ﹤0.01% |
12,117
+3,291
| +37% | +$328K |
|
2717
Amerant Bancorp
AMTB
$1.16B
| $1.16M | ﹤0.01% |
33,588
+24,940
| +288% | +$734K |
|
2718
Brookdale Senior Living
BKD
$3.49B
| $1.16M | ﹤0.01% |
224,658
+149,020
| +197% | +$929K |
|
|
BGFV
2719
DELISTED
Big 5 Sporting Goods
BGFV
| $1.16M | ﹤0.01% |
60,822
+25,083
| +70% | +$626K |
|
2720
Vanguard Information Technology ETF
VGT
$139B
| $1.16M | ﹤0.01% |
20,216
| – | – |
|
2721
Arlo Technologies
ARLO
$1.6B
| $1.16M | ﹤0.01% |
110,259
+43,933
| +66% | +$343K |
|
|
GOOD
2722
Gladstone Commercial Corp
GOOD
$605M
| $1.16M | ﹤0.01% |
44,861
+8,015
| +22% | +$182K |
|
2723
Kirby Corp
KEX
$7.01B
| $1.16M | ﹤0.01% |
19,464
-113,739
| -85% | -$6.36M |
|
2724
Farmers National Banc Corp
FMNB
$939M
| $1.15M | ﹤0.01% |
62,193
+26,890
| +76% | +$479K |
|
|
YI
2725
111 Inc
YI
$33.9M
| $1.15M | ﹤0.01% |
32,980
| – | – |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.